Transdermal [ftcn]
Hormone replacement therapy [topp]
Doppler [diap]
findings [ftcn]
Normotensive [fndg]
hypertensive [fndg]
postmenopausal [tmco]
Patients [podg]
Objective [inpr]
Evaluate [ftcn]
effects [qlco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Plasma viscosity [lbpr]
Thromboxane B2 [eico]
Vascular impedance [orgf]
Uterine wall [blor]
Bladder [bpoc]
internal carotid [bpoc]
Ophthalmic Arteries [bpoc]
Normotensive [fndg]
hypertensive [fndg]
postmenopausal [tmco]
Patients [podg]
Methods [inpr]
postmenopausal [tmco]
Patients [podg]
Continuous [idcn]
Estradiol [horm, phsu, strd]
Transdermal [ftcn]
Supplementation [topp]
Dose [qnco]
MU/day [qnco]
Courses [tmco]
medroxyprogesterone acetate 10 MG [clnd]
2 Months [tmco]
Women [popg]
divided [ftcn]
Group [idcn]
Blood Pressure [orgf]
Normotensive [fndg]
Women [popg]
Group 1 [inpr]
N NOS [aapp, imft]
hypertensive [fndg]
Subject [grup]
Group 2 [inpr]
N NOS [aapp, imft]
Start [tmco]
Hormone replacement therapy [topp]
months [tmco]
therapy [ftcn]
Patients [podg]
Transvaginal [spco]
Pelvic organs, NOS [bpoc]
Doppler [diap]
Velocities, Blood Flow [lbtr]
Uterine wall [blor]
Bladder [bpoc]
internal carotid [bpoc]
Ophthalmic Arteries [bpoc]
Plasma viscosity [lbpr]
Plasma [bdsu]
Thromboxane B2 [eico]
months [tmco]
Hormone replacement therapy [topp]
Plasma viscosity [lbpr]
Bad [qlco]
Decreased [qnco]
Group [idcn]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
P NOS [aapp, imft]
Bad [qlco]
Thromboxane B2 [eico]
Levels [qlco]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
Group 2 [inpr]
P NOS [aapp, imft]
Percentage [qnco]
reduction [npop]
Plasma viscosity [lbpr]
Smaller [qlco]
hypertensive [fndg]
Women [popg]
Normotensive [fndg]
Women [popg]
P NOS [aapp, imft]
reduction [npop]
Vascular impedance [orgf]
Uterine Artery [bpoc]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
Group 2 [inpr]
P NOS [aapp, imft]
Bladder Wall [bpoc]
Arteries [bpoc]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
Group 2 [inpr]
P NOS [aapp, imft]
Carotid Artery, Internal [bpoc]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
Group 2 [inpr]
P NOS [aapp, imft]
Ophthalmic Artery [bpoc]
reduction [npop]
Group 1 [inpr]
P NOS [aapp, imft]
reduction [npop]
P NOS [aapp, imft]
Percentage [qnco]
reduction [npop]
Vascular impedance [orgf]
Group [idcn]
Conclusions [idcn]
Transdermal [ftcn]
Hormone replacement therapy [topp]
effective [qlco]
Reducing [qlco]
Plasma viscosity [lbpr]
Thromboxane B2 [eico]
Levels [qlco]
Vascular impedance [orgf]
Peripheral [spco]
Central [spco]
Vessels [bpoc]
Normotensive [fndg]
hypertensive [fndg]
postmenopausal [tmco]
Patients [podg]
Copyright [inpr]
Published [ocac]
Son [famg]
LTD [ortf]
